Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study
Title:
Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study
Author:
Taplin, Mary-Ellen George, Daniel J. Halabi, Susan Sanford, Ben Febbo, Philip G. Hennessy, Kristen T. Mihos, Christos G. Vogelzang, Nicholas J. Small, Eric J. Kantoff, Philip W.